We are live on ! Find out more
WA

Wasatch Advisors Portfolio holdings

AUM $15.3B
1-Year Est. Return 25.06%
This Fund
S&P 500
This Quarter Est. Return
+12.67%
1 Year Est. Return
+25.06%
3 Year Est. Return
+87.66%
5 Year Est. Return
+80.4%
10 Year Est. Return
+874.7%
AUM
$20.4B
AUM Growth
+$1.71B
Cap. Flow
-$192M
Cap. Flow %
-0.94%
Top 10 Hldgs %
23.81%
Holding
254
New
17
Increased
91
Reduced
119
Closed
17

Top Buys

Rank Stock Value
1
FOUR icon
Shift4
FOUR
+$150M
2
BROS icon
Dutch Bros
BROS
+$102M
3
PCOR icon
Procore
PCOR
+$96.7M
4
MOD icon
Modine Manufacturing
MOD
+$75.9M
5
TREX icon
Trex
TREX
+$71.3M

Sector Composition

Rank Sector Weight
1 Technology 25.68%
2 Industrials 17.79%
3 Consumer Discretionary 15.5%
4 Healthcare 14.57%
5 Financials 14.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HWC icon
126
Hancock Whitney
HWC
$6.19B
$23.8M 0.12%
466,010
-4,050
-0.9% -$206K
CAMT icon
127
Camtek
CAMT
$5.92B
$23.1M 0.11%
289,658
-137,733
-32% -$13.4M
AORT icon
128
Artivion
AORT
$1.34B
$21.7M 0.11%
815,832
-105,717
-11% -$2.75M
ATRC icon
129
AtriCure
ATRC
$2.08B
$21.6M 0.11%
769,252
-20,562
-3% -$507K
ONON icon
130
On Holding
ONON
$12.6B
$21M 0.1%
419,536
+17,362
+4% +$745K
PAR icon
131
PAR Technology
PAR
$716M
$18.8M 0.09%
361,062
-9,445
-3% -$491K
KLIC icon
132
Kulicke & Soffa
KLIC
$4.34B
$18M 0.09%
398,225
+38,655
+11% +$1.71M
PATK icon
133
Patrick Industries
PATK
$2.87B
$17.8M 0.09%
187,803
-453
-0.2% -$38K
SGMO
134
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$16.8M 0.08%
19,442,368
-648,202
-3% -$475K
BASE
135
DELISTED
Couchbase
BASE
$16M 0.08%
990,331
+357,169
+56% +$6.18M
NRIX icon
136
Nurix Therapeutics
NRIX
$2.45B
$15.9M 0.08%
708,377
-149,690
-17% -$3.39M
RDVT icon
137
Red Violet
RDVT
$957M
$15.6M 0.08%
546,880
-153,982
-22% -$4.18M
VKTX icon
138
Viking Therapeutics
VKTX
$3.88B
$14.4M 0.07%
227,720
-25,449
-10% -$1.49M
XPOF icon
139
Xponential Fitness
XPOF
$286M
$14.3M 0.07%
1,152,972
+565,451
+96% +$8.31M
VMD icon
140
Viemed Healthcare
VMD
$447M
$13.6M 0.07%
1,848,884
+303,277
+20% +$2.17M
CMRC
141
Commerce.com Inc Series 1
CMRC
$272M
$13M 0.06%
2,229,881
-1,199,340
-35% -$7.91M
KIDS icon
142
OrthoPediatrics
KIDS
$513M
$12.8M 0.06%
473,101
-62,195
-12% -$1.88M
CERS icon
143
Cerus
CERS
$575M
$12.7M 0.06%
7,325,834
-59,459
-0.8% -$125K
CLMB icon
144
Climb Global Solutions
CLMB
$528M
$12.1M 0.06%
484,312
-159,316
-25% -$3.19M
CTLP
145
DELISTED
Cantaloupe
CTLP
$11.9M 0.06%
1,613,057
+271,782
+20% +$1.87M
NSSC icon
146
Napco Security Technologies
NSSC
$1.3B
$11.9M 0.06%
294,961
-112,430
-28% -$5.51M
SKWD icon
147
Skyward Specialty Insurance
SKWD
$2.53B
$11.9M 0.06%
292,175
+15,681
+6% +$607K
SHOE
148
Shoe Station Group
SHOE
$424M
$11.7M 0.06%
267,687
-33,184
-11% -$1.35M
STRL icon
149
Sterling Infrastructure
STRL
$15.2B
$11.7M 0.06%
80,530
-4,140
-5% -$492K
DYN icon
150
Dyne Therapeutics
DYN
$4.15B
$11.6M 0.06%
324,099
-11,516
-3% -$458K

Similar funds

Wasatch Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Wasatch Advisors held 254 positions worth $20.4B, up 9.1% from $18.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Wasatch Advisors's Q3 2024 filing shows 17 new, 91 increased, 119 reduced and 17 closed positions. Its largest new stake was Modine Manufacturing: 686,748 shares worth $91.2M. The largest sale was FIVE9, an estimated $166M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Wasatch Advisors's largest Q3 2024 buy was Modine Manufacturing: 686,748 shares worth $91.2M.
  • Wasatch Advisors added most to Shift4 in Q3 2024, an estimated $150M increase.
  • Wasatch Advisors's biggest Q3 2024 reduction was Guidewire Software, cutting an estimated $111M.
  • Wasatch Advisors fully exited FIVE9 in Q3 2024, selling an estimated $166M.
  • Wasatch Advisors's ten largest holdings make up 24% of its $20.4B portfolio in Q3 2024.
  • Wasatch Advisors opened 17 new positions and closed 17 in Q3 2024.
  • Wasatch Advisors's portfolio value rose 9.1% quarter-over-quarter to $20.4B.

Based on Wasatch Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.